Cure SMA Urges South Dakota to Make 2021 the Year It Starts to Screen All Newborns for Spinal Muscular Atrophy
News Provided By
Share This Article
While Two-Thirds of U.S. States Now Screen for SMA, South Dakota Newborns Are at Risk for Delayed Diagnosis PIERRE, SOUTH DAKOTA, UNITED STATES, January 25, 2021 /EINPresswire.com/ Building off its most impactful year in state newborn screening for spinal muscular atrophy (SMA), Cure SMA is urging South Dakota to complete implementation in 2021 of newborn screening for SMA the most common genetic cause of mortality for infants in the U.S. This is especially important given the availability of three effective disease-modifying treatments for SMA. As it stands, without statewide screening, newborns in South Dakota are at risk of a delayed diagnosis and profoundly less effective treatment results.